Stem Holdings, Inc. (STMH)

Market Cap	4.76M
Revenue (ttm)	16.41M
Net Income (ttm)	-16.37M
Shares Out	226.55M
EPS (ttm)	-0.07
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,338
Open	0.0140
Previous Close	0.0130
Day's Range	0.0139 - 0.0140
52-Week Range	0.0100 - 0.0780
Beta	0.99
Analysts	Sell
Price Target	2.04 (+14,523.66%)
Earnings Date	Feb 21, 2023

About STMH

Stem Holdings, Inc. operates as a vertically-integrated cannabis products and technology company. It engages in the production, distribution, and sale of cannabis and cannabis-infused products. The company's brands include TJ's Gardens, TravisxJames, and Yerba Buena flower and extracts; Cannavore edible confections; Doseology, a CBD mass-market brand; and delivery-as-a-service brands of Budee and Ganjarunner e-commerce platforms. As of September 30, 2021, it had ownership interests in 29 state issued cannabis licenses, including 9 licenses for ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2016
• Employees: 150
• Stock Exchange: OTCMKTS
• Ticker Symbol: STMH

Financial Performance

In 2022, Stem Holdings's revenue was $16.56 million, a decrease of -53.69% compared to the previous year's $35.77 million. Losses were -$17.37 million, -73.02% less than in 2021.

Analyst Forecast

According to 6 analysts, the average rating for STMH stock is "Sell." The 12-month stock price forecast is $2.04, which is an increase of 14,523.66% from the latest price.

Price Target

$2.04

(14,523.66% upside)

Analyst Consensus: Sell